SCHEMBL6537655

SCHEMBL6537655

CON(C)C(=O)c1cnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc2c1CO[Si](c1ccccc1)(c1ccccc1)C(C)(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 2/20 0.34
PTGES O14684 4/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
SLC16A3 O15427 1/20 0.33
POLB P06746 1/20 0.33
CDK14 O94921 3/20 0.32
CCNY Q8ND76 3/20 0.32
RORC P51449 1/20 0.32
AKR1C3 P42330 1/20 0.32
HTT P42858 2/20 0.32
HSD17B10 Q99714 1/20 0.32
LMNA P02545 2/20 0.32
MAPT P10636 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
ALDH1A1 P00352 1/20 0.32
ABL1 P00519 1/20 0.32
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537961 0.89 SLC16A3 (0.41) GHSRPTGESMEN1KMT2ASLC16A3
SCHEMBL6537544 0.85 PTGES (0.37) GHSRPTGESMEN1KMT2ASLC16A3
SCHEMBL6537510 0.84 SLC16A3 (0.37) GHSRPTGESMEN1KMT2ASLC16A3
SCHEMBL8471310 0.84 SLC16A3 (0.36) GHSRMEN1KMT2ASLC16A3CDK14
SCHEMBL6537404 0.83 SLC16A3 (0.36) GHSRPTGESMEN1KMT2ASLC16A3
SCHEMBL8588641 0.81 SLC16A3 (0.41) GHSRMEN1KMT2ASLC16A3POLB
SCHEMBL6538571 0.81 SLC16A3 (0.38) GHSRPTGESMEN1KMT2ASLC16A3
SCHEMBL6537654 0.78 KMT2A (0.35) GHSRPTGESMEN1KMT2ASLC16A3
SCHEMBL8588643 0.74 SLC16A3 (0.38) MEN1KMT2ASLC16A3HTTLMNA
SCHEMBL6538360 0.74 CYP3A4 (0.40) GHSRMEN1KMT2ASLC16A3POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed